$HAO

Haoxi Health Technology (NASDAQ:HAO) said it signed a strategic cooperation framework with NOVA MEDIA to develop an AI digital marketing system for healthcare advertisers. The platform is intended to use AI digital humans, generative AI, and workflow automation to automate content creation and support campaigns on Toutiao, Douyin, WeChat, and Sina Weibo. No financial terms or timelines were disclosed.

Haoxi Health Technology Limited (HAO) said it signed a strategic cooperation framework with NOVA MEDIA to develop an AI digital marketing system for HAO. The system will use AI digital humans, automated content generation, and workflow automation to support health-industry marketing across platforms including Toutiao, Douyin, WeChat, and Sina Weibo.

Univest Securities, LLC said it helped close a registered direct offering for Haoxi Health Technology Ltd (NASDAQ: HAO). Haoxi raised about $4 million by selling 10,000,000 Class A ordinary shares, or pre-funded warrants, at $0.40 per share. Univest acted as sole placement agent.

Haoxi Health Technology Ltd. (HAO) said it agreed to a registered direct offering of 10 million Class A shares or pre-funded warrants at $0.40 per share, with gross proceeds of about $4 million. The company expects closing July 13, 2026, subject to conditions. HAO shares fell sharply, closing at $0.36 on July 10.

Haoxi Health Technology Ltd (NASDAQ: HAO) said it agreed to sell 10,000,000 Class A ordinary shares, or pre-funded warrants in lieu, at $0.40 per share in a registered direct offering. Gross proceeds are expected at about $4 million, with closing around July 13, 2026, subject to conditions. Univest Securities is the placement agent.

Haoxi Health Technology Ltd director Liu Jia has submitted an initial insider ownership report on Form 3. The filing indicates Liu Jia is a director of the company but shows no reported transactions, share purchases, sales, or derivative positions for the reporting person. The document also provides details on the SEC Form 3 and clarifies that no securities are beneficially owned according to this initial report.

Haoxi Health Technology Ltd (NASDAQ:HAO) announced an $80 million at-the-market (ATM) equity offering program through a sales agreement with Aegis Capital Corp. Aegis Capital will act as the sales agent, receiving a 2.5% commission on gross proceeds, with shares to be sold on the Nasdaq Stock Market. This offering is based on an SEC-effective shelf registration statement from June 2025.

BEIJING, April 21, 2025 ( GLOBE NEWSWIRE ) -- Haoxi Health Technology Limited ( the "Company" or "HAO" ) , an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haoxi Digital Technology Co., Ltd. ( "Haoxi Beijing" ) , a wholly-owned subsidiary of the ...

BEIJING, April 21, 2025 ( GLOBE NEWSWIRE ) -- Haoxi Health Technology Limited ( the "Company" or "HAO" ) , an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haoxi Digital Technology Co., Ltd. ( "Haoxi Beijing" ) , a wholly-owned subsidiary of the ...